Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine

Still Alive and Regenerating

Not all muscle stem cells are made equal...

James Strachan | | Quick Read

Losing muscle mass is a significant problem for older people and is partly due to a loss of the regenerative functions of satellite cells. Now, an international team of researchers have discovered a subgroup of satellite cells that maintain their regenerative capacity over time, declining only at geriatric age (1). 

Their superior regenerative capacity is via the activation of the FoxO signaling pathway – previously associated with longevity – which is lost in later life. 

The scientists hope that their findings will help "harness the potential of stem cells for regenerative medicine in sarcopenia,” with the door now open for therapeutic intervention targeting FoxO expression.

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE!

Login

Forgot your password?

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Manufacture Advanced Medicine
  1. L García-Prat et al., “FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age” Nat Cel Bio, 22, 1307-1318 (2020). PMID: 33106654.

About the Author

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.

From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

Related Webinars

Manufacture Vaccines

Unleashing the Power of Cyclodextrins in Vaccines

| Sponsored by Roquette

Manufacture Advanced Medicine

Fiber-based chromatography to improve productivity in downstream AAV processing

| Sponsored by Cytiva

Manufacture Advanced Medicine

Efficient production process for adeno-associated viral vectors

| Sponsored by Cytiva

Most Popular

1. Business & Regulation Business Practice

Crafting a Culture of Excellence

| Maryam Mahdi

2. Business & Regulation Business Practice

Stemming the Brain Drain

| Kelly Chibale

3. Business & Regulation Business Practice

Building a Beautiful Biotech

| James Strachan

4. Manufacture Formulation

The Rise of Lipid Nanoparticles

| Rahul Keswani, Benjamin King

5. Manufacture Vaccines

COVID-19: Vaccine Development at Full Tilt

| Sheila Rocchio

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker